Page last updated: 2024-08-17

adenosine diphosphate and canagliflozin

adenosine diphosphate has been researched along with canagliflozin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Day, EA; Ford, RJ; Gowans, GJ; Hardie, DG; Hawley, SA; Mancini, SJ; Pitt, RD; Salt, IP; Smith, BK; Steinberg, GR	1

Other Studies

1 other study(ies) available for adenosine diphosphate and canagliflozin

Article	Year
The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels. Diabetes, 2016, Volume: 65, Issue:9 Topics: Adenosine Diphosphate; Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Canagliflozin; Female; Glucose; HEK293 Cells; Humans; Immunoprecipitation; Liver; Male; Mice; Mice, Knockout; Mitochondria; Phosphorylation; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2016

Article

Year

The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.

Diabetes, 2016, Volume: 65, Issue:9

Topics: Adenosine Diphosphate; Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Canagliflozin; Female; Glucose; HEK293 Cells; Humans; Immunoprecipitation; Liver; Male; Mice; Mice, Knockout; Mitochondria; Phosphorylation; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2016